Speedel

Contact
speedelgroup.com
+41612064000

Speedel

Hirschgässlein 11
4051 Basel
Switzerland
+41612064000
speedelgroup.com
Contact
Profile Products News
Contact

About Speedel

Speedel Pharma AG was acquired by Novartis AG. Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. The company was founded in 1998 and is based in Basel, Switzerland.

Read more about Speedel
Facts about Speedel
  • Focus : Manufacturer
  • Industry : Pharma

Product portfolio of Speedel

Product portfolio

Show all

News about Speedel

Speedel

03-Apr-2008 | research and development

SPP100 (Tekturna/Rasilez) reduces left ventricular hypertrophy

Latest study reveals further potential benefits of renin inhibitor in heart disease

Read news
Speedel

22-Jan-2008 | research and development

Speedel: US approval for SPP100 combined with diuretic to treat hypertension

Speedel Holding Ltd announced that the FDA approved a second product containing SPP100 (aliskiren) in the USA for the treatment of hypertension. The ...

Read news
Speedel

26-Sep-2007 | business & finance

Speedel and Novartis win the Wall Street Journal Gold Award

Speedel welcomed the announcement that Speedel and Novartis have won the overall Gold Award in the seventh annual Wall Street Journal contest for ...

Read news
Speedel

18-Sep-2007 | people

Speedel announced appointment to Management Team

Dr Klaus Dembowsky will Head of Speedel Experimenta, Speedel's late-stage research unit. He is a MD and PhD in physiology and has extensive experience in ...

Read news
Speedel

14-Jul-2004 | business & finance

Speedel Receives Major Development Milestones From Novartis

Equity participation and cash payment for Aliskiren SPP100

Read news
Show more news about Speedel

Here you will find Speedel